Perspectives on IDH Mutation in Diffuse Gliomas

Trends in Cancer
Yu-Ting SuJing Wu

Abstract

Isocitrate dehydrogenase (IDH) mutations are biomarkers to classify diffuse gliomas into biologically similar subgroups. Tremendous efforts have been made to understand the biology of IDH-mutant gliomas at the genetic, epigenetic, transcriptional, and protein levels. Preclinical models that recapitulate human tumor biology are crucial not only to our understanding of IDH mutations in gliomagenesis, but also in testing of novel therapeutic agents that may lead to more effective therapies for IDH-mutant glioma patients.

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Hiroaki WakimotoAndrew S Chi
Zhonghua bing li xue za zhi Chinese journal of pathology
Yi PanYan-feng Zhong
Gan to kagaku ryoho. Cancer & chemotherapy
Akitake Mukasa
Chinese Clinical Oncology
Catherine H Han, Tracy T Batchelor
© 2022 Meta ULC. All rights reserved